MODIFIED POLYPEPTIDE
PURPOSE:To provide a chemically, modified polypeptide in which antigenicity is eliminated while retaining the physiological activity of polypeptide at a high level, by subjecting amino groups in the molecule of polypeptide with a group contg. a specified polyethylene glycol residue. CONSTITUTION:Par...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
26.11.1982
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | PURPOSE:To provide a chemically, modified polypeptide in which antigenicity is eliminated while retaining the physiological activity of polypeptide at a high level, by subjecting amino groups in the molecule of polypeptide with a group contg. a specified polyethylene glycol residue. CONSTITUTION:Part or the whle of amino groups in the molecule of polypeptide such as uricase, arginase or insulin is substituted with a group of formulaI (wherein R1 is F, Cl, OH or a group which does not react with the polypeptide; the group of formula II is a polyethylene glycol residue having a number- average MW of 5,000-15,000; R2 is alkyl, an arom. group, alkylcarbonyl, arom. carbonyl, alkylaminocarbonyl, arom. amino carbonyl) to produce a modified polypeptide which is an enzyme having a physiological activity effective in the treatment of patients and in which antigenicity is lowered or completely eliminated while retaining highly the physiological activity of the polypeptide. |
---|---|
Bibliography: | Application Number: JP19810077153 |